Literature DB >> 23667251

Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.

Tingfang Yi1, Evangelos Papadopoulos, Patrick R Hagner, Gerhard Wagner.   

Abstract

Hypoxia promotes tumor evolution and metastasis, and hypoxia-inducible factor-1α (HIF-1α) is a key regulator of hypoxia-related cellular processes in cancer. The eIF4E translation initiation factors, eIF4E1, eIF4E2, and eIF4E3, are essential for translation initiation. However, whether and how HIF-1α affects cap-dependent translation through eIF4Es in hypoxic cancer cells has been unknown. Here, we report that HIF-1α promoted cap-dependent translation of selective mRNAs through up-regulation of eIF4E1 in hypoxic breast cancer cells. Hypoxia-promoted breast cancer tumorsphere growth was HIF-1α-dependent. We found that eIF4E1, not eIF4E2 or eIF4E3, is the dominant eIF4E family member in breast cancer cells under both normoxia and hypoxia conditions. eIF4E3 expression was largely sequestered in breast cancer cells at normoxia and hypoxia. Hypoxia up-regulated the expression of eIF4E1 and eIF4E2, but only eIF4E1 expression was HIF-1α-dependent. In hypoxic cancer cells, HIF-1α-up-regulated eIF4E1 enhanced cap-dependent translation of a subset of mRNAs encoding proteins important for breast cancer cell mammosphere growth. In searching for correlations, we discovered that human eIF4E1 promoter harbors multiple potential hypoxia response elements. Furthermore, using chromatin immunoprecipitation (ChIP) and luciferase and point mutation assays, we found that HIF-1α utilized hypoxia response elements in the human eIF4E1 proximal promoter region to activate eIF4E1 expression. Our study suggests that HIF-1α promotes cap-dependent translation of selective mRNAs through up-regulating eIF4E1, which contributes to tumorsphere growth of breast cancer cells at hypoxia. The data shown provide new insights into protein synthesis mechanisms in cancer cells at low oxygen levels.

Entities:  

Keywords:  Breast Cancer Cells; Cancer Biology; Cap-dependent Translation; Hypoxia; Hypoxia-inducible Factor (HIF); Translation Initiation Factors; eIF4E; mRNA

Mesh:

Substances:

Year:  2013        PMID: 23667251      PMCID: PMC3696647          DOI: 10.1074/jbc.M113.471466

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Translation initiation: structures, mechanisms and evolution.

Authors:  Assen Marintchev; Gerhard Wagner
Journal:  Q Rev Biophys       Date:  2004 Aug-Nov       Impact factor: 5.318

2.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

Authors:  H E Ryan; J Lo; R S Johnson
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer.

Authors:  R Bos; P J van Diest; J S de Jong; P van der Groep; P van der Valk; E van der Wall
Journal:  Histopathology       Date:  2005-01       Impact factor: 5.087

4.  Elevated levels of eukaryotic translation initiation factor eIF-4E, mRNA in a broad spectrum of transformed cell lines.

Authors:  Y Miyagi; A Sugiyama; A Asai; T Okazaki; Y Kuchino; S J Kerr
Journal:  Cancer Lett       Date:  1995-05-08       Impact factor: 8.679

5.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

Authors:  B H Jiang; F Agani; A Passaniti; G L Semenza
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

Review 6.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

7.  Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control.

Authors:  Marianne Koritzinsky; Michaël G Magagnin; Twan van den Beucken; Renaud Seigneuric; Kim Savelkouls; Josée Dostie; Stéphane Pyronnet; Randal J Kaufman; Sherry A Weppler; Jan Willem Voncken; Philippe Lambin; Constantinos Koumenis; Nahum Sonenberg; Bradly G Wouters
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

8.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

9.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

Authors:  P H Maxwell; G U Dachs; J M Gleadle; L G Nicholls; A L Harris; I J Stratford; O Hankinson; C W Pugh; P J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

10.  Hypoxia-induced energy stress regulates mRNA translation and cell growth.

Authors:  Liping Liu; Timothy P Cash; Russell G Jones; Brian Keith; Craig B Thompson; M Celeste Simon
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

View more
  29 in total

Review 1.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

2.  Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.

Authors:  Evangelos Papadopoulos; Simon Jenni; Eihab Kabha; Khuloud J Takrouri; Tingfang Yi; Nicola Salvi; Rafael E Luna; Evripidis Gavathiotis; Poornachandran Mahalingam; Haribabu Arthanari; Ricard Rodriguez-Mias; Revital Yefidoff-Freedman; Bertal H Aktas; Michael Chorev; Jose A Halperin; Gerhard Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

3.  Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.

Authors:  Mona Diab-Assaf; Raefa Abou-Khouzam; Nina Saadallah-Zeidan; Khaled Habib; Nizar Bitar; Walid Karam; Bertrand Liagre; Steve Harakeh; Rania Azar
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 4.  Targeting the translation machinery in cancer.

Authors:  Mamatha Bhat; Nathaniel Robichaud; Laura Hulea; Nahum Sonenberg; Jerry Pelletier; Ivan Topisirovic
Journal:  Nat Rev Drug Discov       Date:  2015-03-06       Impact factor: 84.694

Review 5.  Therapeutic Opportunities in Eukaryotic Translation.

Authors:  Jennifer Chu; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

6.  RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells.

Authors:  Seunghyung Lee; Lawrence E Goldfinger
Journal:  FASEB J       Date:  2014-06-13       Impact factor: 5.191

7.  Systemic Reprogramming of Translation Efficiencies on Oxygen Stimulus.

Authors:  J J David Ho; Miling Wang; Timothy E Audas; Deukwoo Kwon; Steven K Carlsson; Sara Timpano; Sonia L Evagelou; Shaun Brothers; Mark L Gonzalgo; Jonathan R Krieger; Steven Chen; James Uniacke; Stephen Lee
Journal:  Cell Rep       Date:  2016-02-04       Impact factor: 9.423

8.  Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium.

Authors:  Shengfeng Wang; Dezheng Huo; Temidayo O Ogundiran; Oladosu Ojengbede; Wei Zheng; Katherine L Nathanson; Barbara Nemesure; Stefan Ambs; Olufunmilayo I Olopade; Yonglan Zheng
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

9.  Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.

Authors:  Columba de la Parra; Luis D Borrero-Garcia; Ailed Cruz-Collazo; Robert J Schneider; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

Review 10.  New frontiers in translational control of the cancer genome.

Authors:  Morgan L Truitt; Davide Ruggero
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.